Bill · S. 2285· Senate(119-S-2285)
Uterine Cancer Study Act of 2025
- Introduced
- 7/15/2025
- Last activity
- 7/15/2025 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsored by
- Lisa Blunt Rochester
- Cosponsors
- - 2 - 0
- Introduced
- In Committee
What this bill would do
This bill, known as the "Uterine Cancer Study Act of 2025," directs the Secretary of Health and Human Services to conduct a specific study. The investigation focuses on the relationship between hair straighteners and uterine cancer. It places a particular emphasis on the increased incidence of this cancer among women of color. The study will involve coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health. Finally, the Secretary is tasked with determining if the Food and Drug Administration should require more testing on these products.
Yes· 3 of 12
Would women be better off under this?+7
The bill addresses a critical health issue specifically impacting women.
Does this narrow racial gaps in how people are treated?+6
The study specifically focuses on the increased incidence of uterine cancer among women of color.
Would Black Americans be better off under this?+5
The study specifically targets health disparities seen in women of color.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Safety Knowledge: The study aims to review findings regarding the relationship between hair straighteners and uterine cancer to understand potential risks (Section 2(a)(1)).
-
Focus on Vulnerable Groups: The study will consider impacts on women and individuals at risk from all racial and ethnic backgrounds, with a specific focus on women of color (Section 2(a)).
-
Detailed Product Analysis: The results will be broken down by whether the products contain dyes, coloring, bleach, highlights, or perms to provide more specific data (Section 2(a)(3)).
-
Potential for Better Regulation: The study will determine if the Food and Drug Administration needs to impose additional testing requirements on manufacturers to ensure product safety (Section 2(a)(4)).
Potential Negative Impacts for People
- No negative impacts are explicitly mentioned in the text provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Women+7Good For African Americans+5Good For Asian Americans+5Good For Hispanic Americans+5Good For Native Americans+5Good For White Americans+3
- Social Issues And Justice
- Improves Racial Equity+6Improves Gender Equality+4
- Economy And Finance
- Improves Consumer Protection+5
- Education And Technology
- Increases Scientific Research Funding+5
- Healthcare
- Increases Research Funding+5
- Governance And Ideology
- Increases Federal Power+2
- 8/1/2025
- 2 Cosponsors added.
- 7/15/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Angela AlsobrooksDemocrat · Maryland
Cory BookerDemocrat · New Jersey